Pregnancy loss after first-trimester viability in women with sickle cell trait: Time for a reappraisal?

American Journal of Obstetrics and Gynecology

Volumn 194, Issue 6, 2006, Pages 1604-1608

  Taylor, Michelle Y ^a   Wyatt Ashmead, Josephine ^b   Gray, Jermaine ^a   Bofill, James A ^a   Martin, Rick ^a   Morrison, John C ^a  

^a Departments of Obstetrics and Gynecology   (India)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Fetal loss; Placenta; Sickle cell trait

Indexed keywords

ADOLESCENT; ADULT; AMNIONITIS; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HISTIOCYTOSIS; HUMAN; MAJOR CLINICAL STUDY; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SICKLE CELL TRAIT;

ABORTION, SPONTANEOUS; ACUTE DISEASE; AMNION; BIRTH WEIGHT; CASE-CONTROL STUDIES; DELIVERY, OBSTETRIC; FEMALE; FETAL DEATH; FETAL DISEASES; FETAL VIABILITY; GESTATIONAL AGE; HISTIOCYTOSIS; HUMANS; INCIDENCE; INFECTION; MECONIUM; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, FIRST; RETROSPECTIVE STUDIES; SICKLE CELL TRAIT;

EID: 33646756861     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.02.027     Document Type: Article

References (22)

1. Ashley-Koch A., Yang Q., and Olney R. Sickle cell hemoglobin (Hb S) allele and sickle cell disease: a human genome epidemiology review. Am J Epidemiol 151 (2000) 839-845
2. Sickle Cell Disease Guideline Panel. Sickle cell disease: screening, diagnosis, management, and counseling in newborns and infants (1993), Agency for Health Care Policy and Research, US Public Health Service, Rockville (MD) AHCPR publication no. 93-0562; clinical practice guideline no. 6
3. Sun P., Wilburn W., Raynor D., and Jamieson D. Sickle cell disease in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia. Am J Obstet Gynecol 184 (2001) 1127-1130
4. American College of Obstetrics and Gynecology. Hemoglobinopathies in pregnancy (1993), The College, Washington (DC) Technical bulletin no.: 185
5. Perry K., and Morrison J. The diagnosis and management of hemoglobinopathies during pregnancy. Semin Perinatol 14 (1990) 90-102
6. American College of Obstetrics and Gynecology. Hemoglobinopathies in pregnancy (2005), The College, Washington (DC) Practice bulletin no.: 64
7. Baill I., and Witter F. Sickle cell trait and its association with birth weight and urinary tract infections in pregnancy. Int J Gynecol Obstet 33 (1990) 19-21
8. Larabee K., and Monga M. Women with sickle cell trait are at increased risk for preeclampsia. Am J Obstet Gynecol 177 (1997) 425-428
9. Kark J., Posey D., Schumacher H., and Ruehle C. Sickle cell trait as a risk factor for sudden death in physical training. N Engl J Med 317 (1987) 781-787
10. Pastorek G., and Seiler B. Maternal death associated with sickle-cell trait. Am J Obstet Gynecol 151 (1985) 295-297
11. Serjeant G., Loy L., Crowther M., Hambleton I., and Thame M. Outcome of pregnancy in homozygous sickle cell disease. Obstet Gynecol 103 (2004) 1278-1285
12. Smith J., Espeland M., Bellevue R., Bonds D., Brown A., and Koshy M. Pregnancy in sickle cell disease: experience of the cooperative study of sickle cell disease. Obstet Gynecol 87 (1996) 199-204
13. Morrison J.C., and Pryor J.A. Hematologic disorders. in assessment & care of the fetus. In: Eden R.D., and Boehm F.H. (Eds). Physiological, clinical, and medicolegal principles (1990), Appleton & Lange, Norwalk (CT) 274-296
14. Stamilio D., Sehdev H., and Macones M. Pregnant women with sickle cell trait are not at increased risk for developing preeclampsia. Am J Perinatol 20 (2003) 41-48
15. Blattner P., Dar H., and Nitowsky H. Pregnancy outcome in women with sickle cell trait. JAMA 238 (1972) 1392-1394
16. Rappaport V., Velasquez M., and Williams K. Hemoglobinopathies in pregnancy. Obstet Gynecol Clin North Am 31 (2004) 287-317
17. Magann E.F., Chauhan S.P., Bofill J., Waddell D., Rust O.A., and Morrison J.C. Maternal morbidity and mortality associated with intrauterine fetal demise: five-year experience in a tertiary referral hospital. Southern Medical Journal 94 (2001) 493-495
18. Taylor M.Y., Wyatt-Ashmead J., May W., Bofill J.A., and Morrison J.C. Third trimester pregnancy loss in patients with sickle cell trait: a preliminary report. [abstract]. Am J Obstet Gynecol 6 suppl (2004) S85
19. Gomez R., Romero R., Ghezzi F., Yoon B.H., Mazor M., and Berry S.M. The fetal inflammatory response syndrome. Am J Obstet Gynecol 179 (1998) 194-202
20. Johnson R.B., Newman S.L., and Struth A.G. Increased susceptibility to infection in sickle cell disease; defects of opsonization and of splenic function. Birth Defects: Original Article Series 11 (1975) 322-327
21. Patanowitz L., Schwartz R., and Balogh K. The placenta in sickle cell disease. Arch Pathol Lab Med 124 (2000) 1565
22. Altshuler G. A conceptual approach to placental pathology and pregnancy outcome. Semin Diagn Pathol 10 (1993) 204-221